On Monday, June 16th, 2025, Lithea’s Chief Medical Officer Mathias Lidgren, MD, PhD, and Chief Technical Officer Deepak Raina, PhD, presented Lithea’s groundbreaking preclinical work on LIT1001 at a meeting hosted by Østdansk Sarkomgruppe, held at Rigshospitalet in Copenhagen, Denmark. They shared the company’s latest preclinical research and introduced Lithea’s innovative product concept for the local delivery of anticancer agents in osteosarcoma patients. The presentation was well received, generating strong interest and insightful discussions. Attendees also identified several additional potential applications of the technology across other oncology indications, highlighting the broader promise of Lithea’s platform.